Halberd Co. (OTCMKTS:HALB) Sees Significant Increase in Short Interest

Halberd Co. (OTCMKTS:HALB) was the recipient of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 133,008 shares, a growth of 136.4% from the May 14th total of 56,263 shares. Based on an average daily trading volume, of 1,473,527 shares, the days-to-cover ratio is presently 0.1 days.

Halberd Stock Down 16.7%

Halberd stock traded down $0.00 during trading hours on Friday, hitting $0.00. 24,135 shares of the stock were exchanged, compared to its average volume of 812,608. Halberd has a 12 month low of $0.00 and a 12 month high of $0.00.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.